|Systematic (IUPAC) name|
|Mol. mass||624.859 g/mol|
|(what is this?)|
When tested on animal models, tirilazad protects brain tissue, and reduces any brain damage. On the contrary, the drug fails to treat, and even worsens a stroke when studied on a human being.
Usage in treatment of stroke
Tirilazad currently has no usage in the clinical treatment of stroke.
- "Tirilazad for acute ischaemic stroke". Retrieved 2007-07-28.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|